Filing Details

Accession Number:
0001144204-18-041780
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-02 20:03:33
Reporting Period:
2018-07-31
Accepted Time:
2018-08-02 20:03:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1636301 Ltd Global Gull Po Box N-4899, 2/F Bahamas Financial Ctr
Shirley &Amp; Charlotte Streets
Nassau C5 BH1-1000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-31 100,000 $131.50 10,395,614 No 4 S Direct
Common Stock Disposition 2018-08-01 15,111 $127.24 10,380,503 No 4 S Direct
Common Stock Disposition 2018-08-01 4,743 $128.05 10,375,760 No 4 S Direct
Common Stock Disposition 2018-08-01 1,200 $129.21 10,374,560 No 4 S Direct
Common Stock Disposition 2018-08-01 2,700 $130.32 10,371,860 No 4 S Direct
Common Stock Disposition 2018-08-01 1,500 $131.09 10,370,360 No 4 S Direct
Common Stock Disposition 2018-08-01 108 $132.25 10,370,252 No 4 S Direct
Common Stock Disposition 2018-08-02 500 $127.68 10,369,752 No 4 S Direct
Common Stock Disposition 2018-08-02 5,002 $128.78 10,364,750 No 4 S Direct
Common Stock Disposition 2018-08-02 5,215 $129.94 10,359,535 No 4 S Direct
Common Stock Disposition 2018-08-02 3,003 $130.86 10,356,532 No 4 S Direct
Common Stock Disposition 2018-08-02 918 $131.43 10,355,614 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Weighted average price. Price range in multiple transactions was $126.70 to $127.65, inclusive.
  3. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
  4. Weighted average price. Price range in multiple transactions was $127.70 to $128.65, inclusive.
  5. Weighted average price. Price range in multiple transactions was $128.80 to $129.75, inclusive.
  6. Weighted average price. Price range in multiple transactions was $129.80 to $130.75, inclusive.
  7. Weighted average price. Price range in multiple transactions was $130.80 to $131.75, inclusive.
  8. Weighted average price. Price range in multiple transactions was $132.25 to $132.30, inclusive.
  9. Weighted average price. Price range in multiple transactions was $127.30 to $128.25, inclusive.
  10. Weighted average price. Price range in multiple transactions was $128.30 to $129.25, inclusive.
  11. Weighted average price. Price range in multiple transactions was $129.30 to $130.25, inclusive.
  12. Weighted average price. Price range in multiple transactions was $130.30 to $131.20, inclusive.
  13. Weighted average price. Price range in multiple transactions was $131.30 to $131.55, inclusive.